BSR and BHPR guideline for the treatment of systemic sclerosis.
نویسندگان
چکیده
NICE has accredited the process used by the BSR to produce its treatment of systemic sclerosis guidance. Accreditation is valid for 5 years from 10 June 2013. More information on accreditation can be viewed at www.nice.org.uk/accreditation. For full details on our accreditation visit: www.nice.org.uk/accreditation. Centre for Rheumatology, Royal Free Hospital, London, Rheumatology Department, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, Department of Rheumatology, Freeman Hospital, Newcastle upon Tyne, Leeds Institute of Musculoskeletal and Rheumatic Medicine, Chapel Allerton Hospital, Leeds, Rheumatology Department, Musgrove Park Hospital, Taunton, Pharmacy Department, Centre for Rheumatology, Royal Free Hospital, London, UK, Rheumatology and Immunology, UMC Utrecht, Utrecht, The Netherlands and Primary Care, Telford and Wrekin NHS Trust, Telford, Shropshire, UK
منابع مشابه
Balancing on the edge: implications of a UK national audit of the use of BSR-BHPR guidelines for the diagnosis and management of polymyalgia rheumatica
INTRODUCTION The British Society for Rheumatology and British Health Professionals in Rheumatology (BSR-BHPR) guidelines for management of polymyalgia rheumatica (PMR) were published in 2010, aiming to provide guidance for diagnosis, management and disease monitoring. A national study was conducted across multiple rheumatology units throughout the UK in order to study the level of adoption of g...
متن کاملThe 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics.
The last British Society of Rheumatology (BSR) guidelines for the treatment of PsA were published in 2005 when antiTNF therapy was not widely available. At that time only one of the anti-TNF therapies was licensed for the treatment of PsA. Since then, their use in PsA has become more widespread, with multiple anti-TNF drugs licensed for the treatment of PsA and approved for therapy by the Natio...
متن کاملBSR and BHPR guidelines for the management of polymyalgia rheumatica.
PMR is the most common inflammatory rheumatic disease in the elderly and is one of the biggest indications for long-term steroid therapy. There are difficulties in diagnosis, with heterogeneity in presentation, response to steroids and disease course. The aim of these guidelines is a safe and specific diagnostic process for PMR, using continued assessment, and discouragement of hasty initial tr...
متن کاملComment on: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.
SIR, We welcome the collective efforts of Dr Chakravarty and colleagues [1] in producing current revised guidelines on the DMARD therapy in consultation with the British Association of Dermatologists. Undoubtedly a lot of attention and effort had gone into bringing these guidelines up to date. Active collaboration of the British Society for Rheumatology (BSR), British Health Professionals in Rh...
متن کاملImprovement in the management of gout is vital and overdue: an audit from a UK primary care medical practice
BACKGROUND Gout is estimated to affect 1.4% of adults in the UK. Appropriate and timely management is essential to reduce the risk of further flares, complications, and to reduce cardiovascular disease risk. The British Society for Rheumatology and British Health Professionals in Rheumatology (BSR/BHPR) and the European League Against Rheumatism (EULAR) have published guidance regarding the man...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Rheumatology
دوره 55 10 شماره
صفحات -
تاریخ انتشار 2016